Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections
Patients affected by acute coronary syndrome (ACS) or by chronic inflammatory musculoskeletal and connective tissue diseases (i.e. systemic sclerosis), often need antiaggregant therapy (ASA or Clopidogrel). The concomitant use of proton pump inhibitors (PPIs) is suggested to reduce the risk of haemo...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
PAGEPress Publications
2011-06-01
|
| Edice: | Reumatismo |
| On-line přístup: | http://www.reumatismo.org/index.php/reuma/article/view/504 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|